Journal of Cancer Research and Practice (Jun 2024)

Meeting Notes of the Taiwan Neuroendocrine Tumor Society & Taiwan Society of Nuclear Medicine Joint Conference - Peptide Receptor Radionuclide Therapy Targeting for Gastroenteropancreatic Neuroendocrine Tumors: Basic Principles and State-of-the-art Clinical Practice

  • Mei-Fang Cheng,
  • Chih-Chieh Yen,
  • Jeng-Shiun Du,
  • Yu-Li Chiu,
  • Ming-Huang Chen,
  • Hui-Jen Tsai,
  • I-Chen Wu,
  • Hueng-Yuan Shen,
  • Ruoh-Fang Yen,
  • Li-Tzong Chen,
  • On Behalf of Taiwan Neuroendocrine Tumor Society and Taiwan Society of Nuclear Medicine

DOI
https://doi.org/10.4103/ejcrp.eJCRP-D-23-00052
Journal volume & issue
Vol. 11, no. 2
pp. 57 – 61

Abstract

Read online

Objective: The current study aimed to investigate the basic principles and clinical applications, including the selection of proper candidates, follow-up strategies, and radiation protection issues relating to peptide receptor radionuclide therapy (PRRT). Data Sources and Study Selection: We searched various scientific databases using specific keywords. Results: Due to the overexpression of somatostatin receptors in neuroendocrine tumors (NETs), PRRT is currently considered an important therapeutic modality for the management of NETs. Conclusion: PRRT incorporates the systemic administration of a tumor-targeting radiolabeled peptide to patients with tumors, allowing for more precise delivery of radiation doses to tumor sites while sparing normal tissues.

Keywords